Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

JAN 24, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals to Hold; Negative Catalysts Have Passed

Cantor Fitzgerald upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Sell to Hold and raised the price target from $37.00 to $38.00. Cantor Fitzgerald commented, "We believe the company is facing several "investment" years that are likely to adversely impact the bottom line and the stock should therefore only move upwards on evidence of stronger

Tags: UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals to Hold; Negative Catalysts Have Passed,  Cantor Fitzgerald Latest News